首页> 外国专利> EXAMINATION METHOD FOR PREDICTING PROGNOSIS AFTER ADMINISTERING GEMCITABINE HYDROCHLORIDE TO PANCREATIC CANCER PATIENT

EXAMINATION METHOD FOR PREDICTING PROGNOSIS AFTER ADMINISTERING GEMCITABINE HYDROCHLORIDE TO PANCREATIC CANCER PATIENT

机译:盐酸吉西他滨减缓胰腺癌患者预后的检验方法

摘要

PROBLEM TO BE SOLVED: To provide an examination method for predicting the prognosis of a pancreatic cancer patient after administering gemcitabine hydrochloride to the patient.;SOLUTION: The examination method for predicting the prognosis of a pancreatic cancer patient after administering gemcitabine hydrochloride to the patient includes detecting the polymorphism and/or mutation of ABCC1 gene encoding a relevant transporter; wherein the single nucleotide polymorphism in the ABCC1 gene is at least (1): rs4148335, (2): rs4148336 or (3): rs4148340.;COPYRIGHT: (C)2010,JPO&INPIT
机译:要解决的问题:提供一种预测盐酸吉西他滨后胰腺癌患者预后的检查方法。解决方案:解决方案:一种预测盐酸吉西他滨后胰腺癌患者预后的检查方法包括:检测编码相关转运蛋白的ABCC1基因的多态性和/或突变;其中ABCC1基因的单核苷酸多态性至少为(1):rs4148335,(2):rs4148336或(3):rs4148340 .;版权:(C)2010,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号